Slingshot members are tracking this corporate initiative:
Allergan (AGN) Exercises $200MM Option to Acquire Motus Therapeutics and Diabetic Gastroparesis (DG) Drug Relamorelin from Rhythm Holding Company, LLC
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Oct 27, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2017
Don’t see a project related to the strategic initiative you care about?
Related Keywords Option, Diabetic Gastroparesis, Relamorelin, Acquisition